QY Research, Inc.

Global Paclitaxel Market Will Reach 160 Million US$ by 2025

QY Research has also offered an easily navigable platform which will help clients in assessing their as well as their competitive vendors’ value. This unique feature provided by QY Research would not only help top players in the market in placing their strategies but will also guide them in successfully achieving their targets in the extremely competitive market.


City of Industry, CA -- (SBWIRE) -- 10/01/2018 -- This report studies the global Paclitaxel market status and forecast, categorizes the global Paclitaxel market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

Paclitaxel is a white crystalline powder, odorless and tasteless. It is insoluble in water and soluble in chloroform, acetone and other organic solvents.
The classification of Paclitaxel includes Natural Paclitaxel API and Semi-synthetic Paclitaxel API, and the proportion of Natural Paclitaxel API in 2017 is about 31.3%, and the proportion is decreasing trend from 2012 to 2017.

Paclitaxel is widely sales for Ovarian Cancer, Cervical Cancer, Breast Cancer and Others. The most proportion of Paclitaxel is sales in Ovarian Cancer, and the consumption proportion is about 46% in 2017.

North America is the largest consumption place, with a consumption market share nearly 52.3% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 19.6%, China is also an important sales region for the Paclitaxel.

Market competition is intense. Phyton, ScinoPharm, Novasep, Samyang, etc. are the leaders of the industry. They hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.

The global Paclitaxel market is valued at 79 million US$ in 2017 and will reach 160 million US$ by the end of 2025, growing at a CAGR of 9.4% during 2018-2025.

The major manufacturers covered in this report






TAPI (Teva)


Huiang biopharma


Yunnan Hande

Hainan Yew Pharm

Jiangsu Yew Biotechnology

Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/382031/global-paclitaxel-market

Market size split by Region
North America
Central & South America
Middle East & Africa

Buy Full Acne Medication Market Report Now, Report delivery time within 24 hours https://www.qyresearch.com/settlement/pre/087073d291a101b1aacae6cc64a2cc2b,0,1,Global%20Paclitaxel%20Market%20Professional%20Survey%20Report%202018

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com